Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
04/1998
04/30/1998WO1998017302A1 Total synthesis of the amino hip analogue of didemnin a
04/30/1998WO1998017275A1 Semi-synthetic studies toward didemnin analogues
04/30/1998WO1998017274A1 Thrombin inhibitors
04/30/1998WO1998012213A3 Cysteine containing peptides
04/30/1998CA2269881A1 Semi-synthetic studies toward didemnin analogues
04/30/1998CA2269878A1 Total synthesis of the amino hip analogue of didemnin a
04/30/1998CA2268391A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
04/30/1998CA2267260A1 Thrombin inhibitors
04/30/1998CA2263732A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
04/29/1998EP0838474A1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient
04/29/1998EP0838473A1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
04/29/1998EP0838472A1 Peptides binding to low-density lipoproteins
04/29/1998EP0838471A1 Peptide derivatives and angiotensin iv receptor agonist
04/29/1998EP0837877A1 L-aspartyl-l-thienylalanine methyl esters, process for producing them and their use as sweeteners
04/29/1998EP0837875A2 Inhibitors of farnesyl-protein transferase
04/28/1998US5744632 Process for crystallizing L-α-aspartyl-L-phenylalanine methyl ester
04/28/1998US5744627 Boronic compound complexing reagents and complexes
04/28/1998US5744621 Cis-epoxide compounds
04/28/1998US5744496 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors
04/28/1998US5744487 Prolineamide derivatives
04/28/1998US5744486 Pyridinone thrombin inhibitors
04/28/1998US5744481 β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
04/28/1998US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
04/28/1998US5744245 Precious metal composition
04/23/1998WO1998016918A1 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities
04/23/1998WO1998016550A1 Chiral peptide nucleic acids
04/23/1998WO1998016547A1 SELECTIVE FACTOR Xa INHIBITORS
04/23/1998WO1998016546A1 ENZYMATIC METHOD FOR PRODUCING N-FORMYL-α-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER
04/23/1998WO1998016527A1 Benzoxepine derivatives which promote release of growth hormone
04/23/1998WO1998016525A1 SELECTIVE FACTOR Xa INHIBITORS
04/23/1998WO1998016524A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS
04/23/1998WO1998016523A2 Selective factor xa inhibitors
04/23/1998WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
04/23/1998WO1998016502A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
04/23/1998WO1998016240A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
04/23/1998WO1997046207A3 Aromatic heterocyclic derivatives as enzyme inhibitors
04/23/1998CA2268381A1 Selective factor xa inhibitors
04/23/1998CA2268281A1 Selective factor xa inhibitors
04/23/1998CA2268270A1 Heterocyclic derivatives as factor xa inhibitors
04/23/1998CA2268264A1 Selective factor xa inhibitors
04/23/1998CA2268098A1 Aspartate ester inhibitors of interleukin-1.beta. converting enzyme
04/23/1998CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors
04/22/1998EP0837071A1 Tripeptide antithrombotic agents
04/22/1998EP0836616A1 Macrolides
04/22/1998EP0836615A1 New thrombin inhibitors, their preparation and use
04/22/1998EP0836485A2 Cascade polymer complexes
04/21/1998US5741799 Heterocyclic thrombin inhibitors
04/21/1998US5741792 Anticoagulants of sulfonamido heterocyclic thrombin inhibitors
04/21/1998US5741781 Mercaptoalkanoyldipeptide compounds
04/21/1998US5741774 Use of a cytokine regulatory agent to treat rheumatoid arthritis
04/16/1998WO1998015571A1 Modified cytostatic agents
04/16/1998WO1998015535A1 1,4-benzodiazepinones and their uses as cck antagonists
04/16/1998DE19640970A1 Modifizierte Cytostatika Modified cytostatics
04/15/1998EP0835265A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues
04/15/1998EP0835263A2 Somatostatin peptides
04/15/1998EP0835238A1 New cationic and polycationic amphiphiles, reactives containing the same and their use
04/15/1998EP0835123A1 Aminopeptidase p inhibitors and uses thereof
04/15/1998EP0835109A1 Pyridinone-thrombin inhibitors
04/15/1998EP0801655B1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
04/15/1998CN1178797A Oligopeptide derivative containing alpha, gamma-diaminobutanoic acid
04/15/1998CN1038034C Rapid synthesis and screening of peptide mimetics
04/14/1998US5739382 Derivatives of 2-aminobenzenesulphonic acid and of 2-aminobenzenesulphonyl chloride, their preparation and their use as synthetic intermediates
04/14/1998US5739350 CC-1065 analogs
04/14/1998US5739282 Amino acid sequence and dna
04/14/1998US5739280 Para-nitroanilide peptides
04/14/1998US5739279 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents
04/14/1998US5739162 Antagonist for gastrin and/or cholecystokinin b-not a-receptors; side effect reduction; antiulcer agents; opiod-enhancing analgesics; gastrointestinal disorders; anxiolytic agents
04/14/1998US5739157 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
04/14/1998US5739129 Agonist activity
04/14/1998US5739112 Anticoagulants
04/14/1998US5738838 Metal ion-binding domains are labeled with medically useful metal ions for lung imaging
04/09/1998WO1998014593A2 Human telomerase catalytic subunit
04/09/1998WO1998014592A2 Telomerase reverse transcriptase
04/09/1998WO1998014468A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage)
04/09/1998WO1998014459A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage)
04/09/1998WO1998001474A3 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth
04/09/1998WO1997047329A3 Radiopharmaceutical compositions capable of localizing at sites of thrombus
04/09/1998CA2645721A1 Human telomerase reverse transcriptase
04/09/1998CA2267664A1 Human telomerase reverse transcriptase
04/09/1998CA2267493A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage)
04/09/1998CA2267328A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage)
04/09/1998CA2266752A1 Telomerase reverse transcriptase
04/08/1998EP0834572A2 Alpha, gamma-diaminobutyric acid (DAB) containing oligopeptide derivatives
04/08/1998EP0833845A1 Compounds with growth hormone releasing properties
04/08/1998EP0833839A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
04/08/1998EP0833837A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
04/08/1998EP0833835A1 Obesity protein intermediates and their preparation and use
04/08/1998EP0833652A1 Novel kappa receptor selective opioid peptides
04/08/1998EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
04/08/1998EP0558681B1 Treatment for tissue ulceration
04/08/1998EP0558630B1 Retroviral protease inhibitors
04/08/1998CN1178535A Therapeutic compound-fatty acid conjugates
04/08/1998CN1178239A Plastics containing heat stabilizer of acylated sucrose
04/07/1998US5736565 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same
04/07/1998US5736559 Cardiovascular disorders; respiratory system disorders
04/07/1998US5736535 1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase
04/07/1998US5736521 Administering amino acid compound
04/07/1998US5736520 Peptidase inhibitors
04/07/1998US5736519 Enhances reconstitution of cells of hematopoietic and immune systems following radiation or chemotherapy induced suppression
04/07/1998US5736518 Hypotensive agents; analgesics; immuno-modulating; antiinflammatory agents; resistant to enzyme hydrolysis;drugs for oral administering